AMRX Soars On Contract Win, TRPX Looks Ahead With Hope, ALXN To Face FDA In Feb

Today's Daily Dose brings you news about Amneal Pharma's contract with Jerome Stevens; Alexion Pharma's regulatory catalyst in February 2019; FDA's expanded approval for Merck's Keytruda; ProPhase Labs' improving financials and Therapix Biosciences' anticipated milestones.

from RTT - Biotech https://ift.tt/2BuvrhN
via IFTTT